Table 2.
Cox regression analysis for death and/or hospitalization with heart failure at minimum 6 month follow-up
| Univariate model, HR (95% CI) | p | Multivariate model, HR (95% CI) | p | |
|---|---|---|---|---|
| Demographics | ||||
| Age | 1.01 (0.99–1.05) | 0.34 | ||
| Gender | 1.48 (0.84–2.60) | 0.17 | ||
| Clinical Findings | ||||
| Heart rate (b.p.m) | 1.00 (0.98–1.02) | 0.64 | ||
| Systolic blood pressure (mmHg) | 1.00 (0.98–1.01) | 0.38 | ||
| Diastolic blood pressure (mmHg) | 0.97 (0.95–1.00) | 0.03 | 0.99 (0.97–1.02) | 0.48 |
| NYHA III/IV | 1.80 (1.02–3.17) | 0.04 | 1.55 (0.83–2.89) | 0.17 |
| Medical history | ||||
| Hypertension | 2.40 (0.58–9.87) | 0.23 | ||
| Diabetes | 1.03 (0.59–1.79) | 0.91 | ||
| Biochemistry | ||||
| Sodium (mmol/L) | 0.97 (0.90–1.05) | 0.45 | ||
| Urea (mmol/L) | 1.09 (1.02–1.15) | 0.01 | 1.10 (1.01–1.21) | 0.04 |
| eGFR (ml/min per 1.73m2) | 0.99 (0.97–1.00) | 0.07 | 1.01 (0.99–1.03) | 0.37 |
| ZLog BNP (ng/L) | 1.47 (1.08–2.01) | 0.02 | 1.44 (1.03–2.02) | 0.03 |
| CMR findings | ||||
| New diagnoses group | 1.75 (1.00–3.07) | 0.05 | 1.92 (1.06–3.45) | 0.03 |
Abbreviations are as for Table 1 and HR hazard ratio, CI confidence interval